XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 1,826,194 $ 16 $ 2,963,342 $ 544 $ (1,137,708)
Beginning balance, shares at Dec. 31, 2023   164,674,594      
Issuance of common stock pursuant to stock option exercises 810   810    
Issuance of common stock pursuant to stock option exercises, shares   73,342      
Issuance of common stock related to vesting of restricted stock units, shares   165,078      
Stock-based compensation expense 16,208   16,208    
Net unrealized gain (loss) on marketable securities (1,742)     (1,742)  
Net Income (Loss) (116,003)       (116,003)
Ending balance at Mar. 31, 2024 1,725,467 $ 16 2,980,360 (1,198) (1,253,711)
Ending balance, shares at Mar. 31, 2024   164,913,014      
Beginning balance at Dec. 31, 2023 1,826,194 $ 16 2,963,342 544 (1,137,708)
Beginning balance, shares at Dec. 31, 2023   164,674,594      
Ending balance at Dec. 31, 2024 2,265,204 $ 18 4,001,666 1,321 (1,737,801)
Ending balance, shares at Dec. 31, 2024   185,896,625      
Issuance of common stock pursuant to stock option exercises 891   891    
Issuance of common stock pursuant to stock option exercises, shares   90,043      
Issuance of common stock related to vesting of restricted stock units, shares   271,536      
Exercise of warrants, Shares   2      
Exercise of warrants, Value 1   1    
Stock-based compensation expense 25,084   25,084    
Net unrealized gain (loss) on marketable securities 386     386  
Net Income (Loss) (213,416)       (213,416)
Ending balance at Mar. 31, 2025 $ 2,078,150 $ 18 $ 4,027,642 $ 1,707 $ (1,951,217)
Ending balance, shares at Mar. 31, 2025   186,258,206